Multiple myeloma is hematological cancer that involves a plasma cell, a type of white blood cell. Abnormal plasma cells, called myeloma cells, grow uncontrolled in a manner that produces bulky tumors in the body’s bone marrow. Patients with multiple myeloma often experience symptoms such as fatigue, diarrhea, peripheral neuropathies, and pain that decrease quality of life while presenting a management challenge for the healthcare team. New technologies and advances in medication have offered treatment options for patients that develop resistance to conventional therapy.
The goal of this course is to provide nurses with the latest knowledge about the diagnosis of multiple myeloma, as well as treatment options and clinical interventions for the disease.
Multiple myeloma is hematological cancer that involves a plasma cell, a type of white blood cell. Abnormal plasma cells, called myeloma cells, grow uncontrolled in a manner that produces bulky tumors in the body’s bone marrow. Patients with multiple myeloma often experience symptoms such as fatigue, diarrhea, peripheral neuropathies, and pain that decrease quality of life while presenting a management challenge for the healthcare team. New technologies and advances in medication have offered treatment options for patients that develop resistance to conventional therapy. The goal of this course is to provide nurses with the latest knowledge about the diagnosis of multiple myeloma, as well as treatment options and clinical interventions for the disease.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
Georgia Board of Nursing (CEBroker Provider #50-290)
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.00 contact hours for participating in this course.
Mississippi Board of Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
Outline:
Complications Related to Multiple Myeloma
Section 3: Treating Multiple Myeloma
Hematopoietic Stem Cell Transplantation (HSCT)
Monica Caicedo Orellana, MS, RN, OCN, is an SME writer for Relias with over 20 years of acute care experience in nursing. She has served in several leadership roles in the acute care setting, the medical-surgical division, and as a nurse educator. She has mentored nurses in renal and oncology specialties. She has been involved in various institutional committees and quality improvement projects. Monica is passionate about professional nursing standards and fostering an environment of continuous lifelong learning as an instrument to improve patient care.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.